Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis. - Muhanna Z; Al Zyoud M; Issa A; Awidi M (Targeted oncology, 2025)